BRIEF published on 12/04/2025 at 16:05, 9 months 9 days ago The Vulnerability of Gold Refineries: SMX's Solution Regulatory Changes SMX Technology Compliance Risks Molecular Identity Gold Refineries
BRIEF published on 12/04/2025 at 16:05, 9 months 9 days ago La vulnérabilité des raffineries d'or : la solution de SMX Technologie SMX Changements Réglementaires Identité Moléculaire Raffineries D'or Risques De Conformité
BRIEF published on 12/04/2025 at 16:01, 9 months 9 days ago Vanguard Group's Disclosure on Qualcomm Securities Securities Form 8.3 Disclosure Vanguard Group Qualcomm
BRIEF published on 12/04/2025 at 16:01, 9 months 9 days ago Information communiquée par Vanguard Group sur Qualcomm Securities Titres Groupe Vanguard Divulgation Formulaire 8.3 Qualcomm
BRIEF published on 12/04/2025 at 16:00, 9 months 9 days ago Vanguard Discloses Stake in American Axle & Manufacturing Takeover Code Vanguard Group Stake Disclosure Share Transactions American Axle
BRIEF published on 12/04/2025 at 16:00, 9 months 9 days ago Vanguard révèle sa participation dans American Axle & Manufacturing Groupe Vanguard Code De Prise De Contrôle Déclaration De Participation Transactions Sur Actions Essieu Américain
BRIEF published on 12/04/2025 at 15:58, 9 months 9 days ago The Vanguard Group, Inc. Discloses Interest in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
BRIEF published on 12/04/2025 at 15:58, 9 months 9 days ago Le groupe Vanguard révèle sa participation dans JTC plc Code De Prise De Contrôle Le Groupe Vanguard Formulaire 8.3 JTC Plc Informations Sur Les Valeurs Mobilières
BRIEF published on 12/04/2025 at 15:57, 9 months 9 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 12/04/2025 at 15:57, 9 months 9 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Avadel Pharmaceuticals Panel Irlandais Des OPA
Published on 09/12/2026 at 02:35, 1 day 18 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 21 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 23 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 3 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 3 hours 50 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 2 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 13 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 22 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 22 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 13 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 13 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 1 hour ago Availability of the 2026 Interim Financial Report
